Olivia C. Ware

Companies

• Contineum Therapeutics, Inc.Board member Apr 4, 2024 to now¹
• Arcellx, Inc.Board member May 17, 2022 to now²
• Revance Therapeutics, Inc.Board member Mar 10, 2021 to Feb 6, 2025³
• CytRxChief Commercial Officer Jan 14, 2016 to Jan 14, 2016⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRevance Therapeutics, Inc.0 shares⁵Feb 6, 2025
• AArcellx, Inc.0 shares⁶Apr 16, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 6, 2025Returned to company 15,000 shares of Revance Therapeutics, Inc.⁵
• Feb 4, 2025U 16,675 shares at $3.65 of Revance Therapeutics, Inc.⁵
• May 1, 2024Granted 15,000 shares of Revance Therapeutics, Inc.⁷
• Apr 16, 2024Sold 2,612 shares at $56.03 of Arcellx, Inc.⁶
• Apr 16, 2024Sold 6,790 shares at $55.36 of Arcellx, Inc.⁶
• Apr 16, 2024Exercised options 9,402 shares at $7.61 of Arcellx, Inc.⁶
• Mar 15, 2024Sold 3,337 shares at $70.99 of Arcellx, Inc.⁸
• Mar 15, 2024Sold 3,763 shares at $70.36 of Arcellx, Inc.⁸
• Mar 15, 2024Sold 1,900 shares at $69.44 of Arcellx, Inc.⁸
• Mar 15, 2024Exercised options 9,000 shares at $7.61 of Arcellx, Inc.⁸
• May 3, 2023Granted 3,534 shares of Revance Therapeutics, Inc.⁹
• May 4, 2022Granted 6,059 shares of Revance Therapeutics, Inc.¹⁰